Protective effects of lipopolysaccharide preconditioning against nitric oxide neurotoxicity

Journal of Neuroscience Research

Volumn 86, Issue 6, 2008, Pages 1277-1289

  Huang, Chia Yen ^a,b   Yang, Hui I ^a   Chen, Shang Der ^c   Shaw, Fu Zen ^d   Yang, Ding I ^e  

^a TZU CHI UNIVERSITY   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bcl 2; Cerebral ischemia; cGMP dependent protein kinase; Endothelial nitric oxide synthase; Oxidative stress

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 8 BROMO CYCLIC GMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; KT 5823; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; ORNITHINE DERIVATIVE; PROTEIN BCL 2;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG MECHANISM; FETUS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TISSUE CULTURE;

ANIMALS; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; CYCLIC GMP; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; LIPOPOLYSACCHARIDES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NERVE DEGENERATION; NEURONS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 42449145099     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21594     Document Type: Article

References (42)

1. Ahmed SH, He YY, Nassief A, Xu J, Xu XM, Hsu CY, Faraci FM. 2000. Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke 31:193-199.
2. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624.
3. Belosjorow S, Schulz R, Dorge H, Schade FU, Heusch G. 1999. Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am J Physiol 277:H2470-H2475.
4. Bredt DS, Snyder SH. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 87:682-685.
5. Bredt DS, Hwang PM, Snyder SH. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770.
6. Chen Y, Ginis I, Hallenbeck JM. 2001. The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells. J Cereb Blood Flow Metab 21:34-40.
7. Ciani E, Guidi S, Bartesaghi R, Contestabile A. 2002. Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem 82:1282-1289.
8. Furuya K, Ginis I, Takeda H, Chen Y, Hallenbeck JM. 2001. Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metab 21:226-232.
9. Furuya K, Zhu L, Kawahara N, Abe O, Kirino T. 2005. Differences in infarct evolution between lipopolysaccharide-induced tolerant and non-tolerant conditions to focal cerebral ischemia. J Neurosurg 103:715-723.
10. Gidday JM. 2006. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7:437-448.
11. Gobeil F Jr, Zhu T, Brault S, Geha A, Vazquez-Tello A, Fortier A, Barbaz D, Checchin D, Hou X, Nader M, Bkaily G, Gratton JP, Heveker N, Ribeiro-da-Silva A, Peri K, Bard H, Chorvatova A, D'Orleans-Juste P, Goetzl EJ, Chemtob S. 2006. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. J Biol Chem 281:16058-16067.
12. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA. 1996. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 16:981-987.
13. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. 1997. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17:9157-9164.
14. Iwase K, Miyanaka K, Shimizu A, Nagasaki A, Gotoh T, Mori M, Takiguchi M. 2000. Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment. J Biol Chem 275:11929-11933.
15. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. 1992. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267:14519-14522.
16. Jiang MH, Hada J. 2007. Early and sharp nitric oxide production and anoxic depolarization in the rat hippocampus during transient forebrain ischemia. Eur J Pharmacol 567:83-88.
17. Ju TC, Yang YT, Yang DI. 2004. Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat. Neurosci Lett 362:226-231.
18. Ju TC, Chen SD, Liu CC, Yang DI. 2005. Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity. Free Radic Biol Med 38:938-949.
19. Kang WS, Tamarkin FJ, Wheeler MA, Weiss RM. 2004. Rapid up-regulation of endothelial nitric-oxide synthase in a mouse model of Escherichia coli lipopolysaccharide-induced bladder inflammation. J Pharmacol Exp Ther 310:452-458.
20. Klinz FJ, Schmidt A, Schinkothe T, Arnhold S, Desai B, Popken F, Brixius K, Schwinger R, Mehlhorn U, Staib P, Addicks K, Bloch W. 2005. Phospho-eNOS Ser-114 in human mesenchymal stem cells: constitutive phosphorylation, nuclear localization and upregulation during mitosis. Eur J Cell Biol 84:809-818.
21. Leker RR, Teichner A, Ovadia H, Keshet E, Reinherz E, Ben-Hur T. 2001. Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor. Brain Res 909:1-7.
22. Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC, Simon RP. 2005. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 25:234-246.
23. Meng X, Brown JM, Ao L, Nordeen SK, Franklin W, Harken AH, Banerjee A. 1996. Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats. Am J Physiol 271:C1316-C1324.
24. Meng X, Brown JM, Ao L, Rowland RT, Nordeen SK, Banerjee A, Harken AH. 1998. Myocardial gene reprogramming associated with a cardiac cross-resistant state induced by LPS preconditioning. Am J Physiol 275:C475-483.
25. Puisieux F, Deplanque D, Pu Q, Souil E, Bastide M, Bordet R. 2000. Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide-induced brain ischemic tolerance. Eur J Pharmacol 389:71-78.
26. Radford NB, Fina M, Benjamin IJ, Moreadith RW, Graves KH, Zhao P, Gavva S, Wiethoff A, Sherry AD, Malloy CR, Williams RS. 1996. Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci U S A 93:2339-2342.
27. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP. 2004. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35:2576-2581.
28. Shen J, Ma S, Chan P, Lee W, Fung PC, Cheung RT, Tong Y, Liu KJ. 2006. Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury. J Neurochem 96:1078-1089.
29. Shimizu S, Nagayama T, Jin KL, Zhu L, Loeffert JE, Watkins SC, Graham SH, Simon RP. 2001. bcl-2 Antisense treatment prevents induction of tolerance to focal ischemia in the rat brain. J Cereb Blood Flow Metab 21:233-243.
30. Shimizu-Sasamata M, Bosque-Hamilton P, Huang PL, Moskowitz MA, Lo EH. 1998. Attenuated neurotransmitter release and spreading depression-like depolarizations after focal ischemia in mutant mice with disrupted type I nitric oxide synthase gene. J Neurosci 18:9564-9571.
31. Souvannavong V, Lemaire C, Chaby R. 2004. Lipopolysaccharide protects primary B lymphocytes from apoptosis by preventing mitochondrial dysfunction and bax translocation to mitochondria. Infect Immun 72:3260-3266.
32. Toyoda T, Kassell NF, Lee KS. 2000. Induction of tolerance against ischemia/reperfusion injury in the rat brain by preconditioning with the endotoxin analog diphosphoryl lipid A. J Neurosurg 92:435-441.
33. Tsai SK, Hung LM, Fu YT, Cheng H, Nien MW, Liu HY, Zhang FB, Huang SS. 2007. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46:346-353.
34. Wang Q, Patton WF, Hechtman HB, Shepro D. 1997. A novel anti-inflammatory peptide inhibits endothelial cell cytoskeletal rearrangement, nitric oxide synthase translocation, and paracellular permeability increases. J Cell Physiol 172:171-182.
35. Wang YP, Sato C, Mizoguchi K, Yamashita Y, Oe M, Maeta H. 2002. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res 56:33-42.
36. Xi L, Jarrett NC, Hess ML, Kukreja RC. 1999. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation 99:2157-2163.
37. Xie Q-w, Cho H, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
38. Yang DI, Yin JH, Ju TC, Chen LS, Hsu CY. 2004. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione. Free Radic Biol Med 36:1317-1328.
39. Yang SN, Yang CH, Huang LT, Wu YT, Wang CL. 2002. Enhancement of CREBSerine-133 phosphorylation through nitric oxide-mediated signaling induced by bacterial lipopolysaccharide in vascular smooth muscle cells from rats. Chin J Physiol 45:69-74.
40. Yang YT, Ju TC, Yang DI. 2005. Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. J Neurochem 93:513-525.
41. Yin JH, Yang DI, Chou H, Thompson EM, Xu J, Hsu CY. 2001. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in C6 glioma cells. J Pharmacol Exp Ther 297:308-315.
42. Zimmermann C, Ginis I, Furuya K, Klimanis D, Ruetzler C, Spatz M, Hallenbeck JM. 2001. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res 895:59-65.